This program addresses the massive problem of iatrogenic injury and death, the inadequacy of the law’s conventional response, and several of the more innovative approaches the law might be taking in the future to raise the level of patient safety. Those more innovative approaches will be more regulatory than litigative.
Three areas to be discussed are new incentives for investment in safety, error reporting, and engaged surveillance.
Learning Objectives:
• Acquire a more complete picture of the nature and extent of the problem of iatrogenic harm.
• Understand the limited efficacy of malpractice liability in encouraging prevention of harm.
• Learn about new incentives (existing and proposed) to create a business case for patient safety.
• Learn about failings of error reporting regimes.
• Learn about engaged surveillance.
MODERATED-This course is designed to inform patent practitioners on the bounds of the Hatch-Waxman S...
MODERATED-This CLE will cover the critical ethics issues involving multijurisdictional practice and ...
MODERATED-Session 4 of 10 - Mr. Kornblum, a highly experienced trial and litigation lawyer for over ...
MODERATED- I’m ok. I can work this out for myself. I’m not like a “real” ...
Large World Models (LWMs)— the next generation of AI systems capable of generating...
MODERATED-Session 8 of 10 -Mr. Kornblum, a highly experienced trial and litigation lawyer for over 5...
Scam typologies help legal professionals by providing a framework to understand, identify, and preve...
The always idiosyncratic Nassim Taleb likes to say, “Nothing is more permanent than ‘tem...
MODERATED-Session 5 of 10 - Mr. Kornblum, a highly experienced trial and litigation lawyer for over ...
MODERATED-Session 6 of 10 - Mr. Kornblum, a highly experienced trial and litigation lawyer for over ...